Table 1.
Adolescence | Young adulthood | Young to midadulthood | Late adulthood | |||
Biomarker outcomesa | Model | Add Health; age 12–18 | Add Health; age 24–32 | MIDUS; age 25–64 | HRS; age 50–98 | NSHAPb; age 57–91 |
Inflammation | Basicc | 0.74* | 0.76* | 1.03 | 0.86** | 0.59* |
(0.57, 0.97) | (0.61, 0.96) | (0.53, 1.98) | (0.78, 0.94) | (0.37, 0.95) | ||
Fulld | 0.99 | 0.79† | 1.07 | 0.89* | 0.77 | |
(0.76, 1.29) | (0.62, 1.00) | (0.55, 2.10) | (0.81, 0.98) | (0.48, 1.23) | ||
N | 6,747 | 6,747 | 863 | 4,323 | 1,153 | |
Hypertension | Basicc | 0.90 | 1.12 | 1.74 | 0.87* | 0.46** |
(0.65, 1.24) | (0.80, 1.57) | (0.81, 3.76) | (0.78, 0.89) | (0.25, 0.85) | ||
Fulld | 1.09 | 1.16 | 1.69 | 0.89* | 0.41** | |
(0.78, 1.52) | (0.83, 1.63) | (0.73, 3.93) | (0.80, 0.99) | (0.22, 0.76) | ||
N | 7,561 | 7,561 | 863 | 4,323 | 1,433 | |
Abdominal | Basicc | 0.52*** | 0.81** | 1.28 | 0.96 | 0.71 |
Obesity | (0.39, 0.68) | (0.63, 1.03) | (0.62, 2.65) | (0.86, 1.07) | (0.29, 1.79) | |
Fulld | 0.75 | 0.68† | 0.81 | 1.01 | 0.91 | |
(0.49, 1.13) | (0.44, 1.04) | (0.26, 2.53) | (0.90, 1.14) | (0.38, 2.20) | ||
N | 7,889 | 7,889 | 863 | 4,323 | 1,423 | |
Overall | Basicc | 0.59*** | 0.97 | 1.50 | 1.03 | 0.34* |
Obesity | (0.44, 0.78) | (0.75, 1.26) | (0.72, 3.12) | (0.93, 1.14) | (0.13, 0.86) | |
Fulld | 0.66** | 1.07 | 1.70 | 1.09 | 0.44† | |
(0.49, 0.88) | (0.82, 1.40) | (0.79, 3.65) | (0.97, 1.22) | (0.19, 1.00) | ||
N | 7,889 | 7,889 | 863 | 4,323 | 1,388 |
***P < 0.001, **P < 0.01, *P < 0.05, †P < 0.1 (two-tailed test).
Measures and cut points used for each marker in Table S1.
Results for inflammation are based on data at wave 1 only; results for the other three markers are based on data at waves 1 and 2 and longitudinal residual change models.
Adjusted for age, sex, and race.
Adjusted for the full set of covariates in Table S3 for each dataset.